Antibiotic agent development
The company develops and commercializes antibiotic agents directed against resistant pathogenic bacterial strains.
Source: LinkedIn company description · Retrieved October 13, 2026
Omnix Medical is a clinical company focused on developing and commercializing antibiotic agents against resistant pathogenic bacterial strains.
Its antibiotic agents are based on natural antimicrobial peptides that are genetically engineered for therapeutic use. The company identifies resistant bacterial strains as a common problem in medicine, particularly in chronic conditions and modern hospitals.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company addresses people in the United States and worldwide who suffer from infections associated with resistant bacteria.
The company develops and commercializes antibiotic agents directed against resistant pathogenic bacterial strains.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026 and September 18, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.